Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Fletcher

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 27, 2012
Pharmacophore identification of c-Myc inhibitor 10074-G5Jeremy L Yap, Huabo Wang, Angela Hu, et al.
Organic Letters|June 15, 2013
Amphipathic α-helix mimetics based on a 1,2-diphenylacetylene scaffoldKwan-Young Jung, Kenno Vanommeslaeghe, Maryanna E Lanning, et al.
Chemmedchem|February 5, 2016
Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted NicotinatesBrandon Drennen, Jacob A Scheenstra, Jeremy L Yap, et al.
Theranostics|August 2, 2021
Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathwaysAlexander Zheleznyak, Matthew Mixdorf, Lynne Marsala, et al.
Drug Design, Development and Therapy|May 20, 2015
Structure-activity exploration of a small-molecule Lipid II inhibitorSteven Fletcher, Wenbo Yu, Jing Huang, et al.
Bioengineering & Translational Medicine|January 9, 2024
Multimodal nanoparticle-containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammationNhu Truong, Andrea L Cottingham, Shruti Dharmaraj, et al.
Cancer Gene Therapy|April 20, 2022
3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growthSanjeev Shukla, Steven Fletcher, Jay Chauhan, et al.
Nature Communications|April 23, 2022
Enabling reactive microscopy with MicroMatorZachary R Fox, Steven Fletcher, Achille Fraisse, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536Lijia Chen, Jeremy L Yap, Makoto Yoshioka, et al.
Investigational New Drugs|February 20, 2026
A novel aurora kinase molecular glue-based degrader sp-2-067 inhibits prostate cancer cell growth and alters immune profileSanjeev Shukla, Sarah Pogash, Arjun Venkatesh, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|November 27, 2012
Pharmacophore identification of c-Myc inhibitor 10074-G5Jeremy L Yap, Huabo Wang, Angela Hu, et al.
Organic Letters|June 15, 2013
Amphipathic α-helix mimetics based on a 1,2-diphenylacetylene scaffoldKwan-Young Jung, Kenno Vanommeslaeghe, Maryanna E Lanning, et al.
Chemmedchem|February 5, 2016
Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted NicotinatesBrandon Drennen, Jacob A Scheenstra, Jeremy L Yap, et al.
Theranostics|August 2, 2021
Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathwaysAlexander Zheleznyak, Matthew Mixdorf, Lynne Marsala, et al.
Drug Design, Development and Therapy|May 20, 2015
Structure-activity exploration of a small-molecule Lipid II inhibitorSteven Fletcher, Wenbo Yu, Jing Huang, et al.
Bioengineering & Translational Medicine|January 9, 2024
Multimodal nanoparticle-containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammationNhu Truong, Andrea L Cottingham, Shruti Dharmaraj, et al.
Cancer Gene Therapy|April 20, 2022
3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growthSanjeev Shukla, Steven Fletcher, Jay Chauhan, et al.
Nature Communications|April 23, 2022
Enabling reactive microscopy with MicroMatorZachary R Fox, Steven Fletcher, Achille Fraisse, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536Lijia Chen, Jeremy L Yap, Makoto Yoshioka, et al.
Investigational New Drugs|February 20, 2026
A novel aurora kinase molecular glue-based degrader sp-2-067 inhibits prostate cancer cell growth and alters immune profileSanjeev Shukla, Sarah Pogash, Arjun Venkatesh, et al.
Pageof 12